100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
NURS 5334 EXAM 3 QUESTIONS AND VERIFIED ANSWERS 2025 $10.49
Add to cart

Exam (elaborations)

NURS 5334 EXAM 3 QUESTIONS AND VERIFIED ANSWERS 2025

 1 view  0 purchase
  • Course
  • N5334
  • Institution
  • N5334

NURS 5334 EXAM 3 QUESTIONS AND VERIFIED ANSWERS 2025

Preview 4 out of 40  pages

  • December 16, 2024
  • 40
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • N5334
  • N5334
avatar-seller
AcademicACHIEVER
NURS 5334 EXAM 3 QUESTIONS AND VERIFIED
ANSWERS 2025

WhatQdrugsQareQusedQtoQtreatQgestationalQdiabetes?Q-QcorrectQanswer-MetforminQabdQInsulin


WhatQA1CQvalueQindicatesQdiabetesQmellitus?QPre-DM?Q-QcorrectQanswer-
6.5%QorQgreaterQisQconsideredQdiabetesQoQ5.7-6.4%pre-diabetes


WhatQfastingQandQrandomQvaluesQindicateQDM?Q-QcorrectQanswer-FastingQplasmaQglucose—
126QorQgreaterQisQdiabetes.QRandomQ(casual)QplasmaQglucose—anythingQgreaterQthanQ200QisQdiabetes


WhatQareQcomplicationsQofQinsulinQtherapy?Q-QcorrectQanswer-Hypoglycemia
CanQdevelopQlipohypertrophy.QAccumulationQofQsubcutaneousQfatQthatQoccursQwhenQitQisQinjectedQtooQfreq
uentlyQatQtheQsameQsite.QAllergicQreactions
CharacterizedQbyQredQandQintenselyQitchyQwelts,QbreathingQbecomesQdifficult
Q



IfQsevereQallergyQdevelops:
Q



DesensitizationQprocedureQ(smallQdosesQtoQlargerQdoses).QHypokalemia
Q



QPromotesQtheQuptakeQofQpotassiumQcellsQandQinsulinQactivatesQaQmembrane-
boundQenzymeQwithQsodiumQpotassiumQandQATPaseQthatQpumpsQpotassiumQintoQtheQcellsQandQsodiumQout


insulinQdrugQinteractionsQ-QcorrectQanswer-oQHypoglycemicagents
CanQintensifyQtheQhypoglycemiaQincludedQbyQinsulin
Q



Examples:Qsulfonylureas,Qglinides,QalcoholQoQUsewithcautionwithhyperglycemicagents
Q



Examples:QthiazideQandQglucocorticoidsQandQsympathomimetics
Q




WhatQeffectQdoQbetaQblockersQhaveQonQinsulin?Q-QcorrectQanswer-
delayQawarenessQofQandQresponseQtoQhypoglycemiaQbyQmaskingQtheQsignsQthatQareQassociatedQwithQstimul
ationQofQsympatheticQnervousQsystem
oQImpairglycogenolysis
oQPreventQtheQbodiesQcounter-regulatoryQresponse

,WhatQareQotherQtherapeuticQusesQbesidesQDM?Q-QcorrectQanswer-
HyperkalemiaQoQAidsQinQdiagnosisQofQGHQdeficiencyQoQDiabeticketoacidosis


InsulinQdosageQmustQbeQcoordinatedQwithQwhat?Q-QcorrectQanswer-CarbohydrateQintake


WhatQisQB/PQgoalQinQdiabetic?Q-QcorrectQanswer-oQToQbeQcontrolled,QwithinQnormalQ120/80


WhatQmedicationQcanQbeQgivenQtoQdecreaseQriskQofQdiabeticQnephropathy?Q-QcorrectQanswer-
ACEQinhibitorQorQARB


WhatQroleQdoesQexerciseQplayQinQtreatmentQofQbothQtypeQ1QandQtypeQ2QDM?Q-QcorrectQanswer-
ExerciseQincreasesQcellularQresponsivenessQtoQinsulinQandQincreasesQglucoseQtoleranceQoQ150QminuteQperQ
weekQofQmoderateQintensityQexerciseQisQrecommended


WhatQareQtheQ4QstepsQinQtheQ4-stepQapproach?Q-QcorrectQanswer-Step1—diagnosis
LifestyleQchangesQplusQmetforminQoQStep2
Q



QLifestyleQchangesQplusQmetforminQandQaQsecondQdrugQ(sulfonylurea,QTZDQorQaQDPP4Qinhibitor,QaQsodiu
mQglucoseQcotransporterQorQSGLT-2Qinhibitor,QaQglucagon-likeQpeptideQ1,QorQaQGLP-
1QreceptorQagonistQorQbasalQinsulin
QSecondQdrugQchoiceQmadeQconsideringQefficacy,QtheQhypoglycemiaQriskQofQtheQpatient,QtheQpatientQtolera
bility,QandQweight-relatedQconsiderationsQ(someQhelpQweightQloss,QsomeQcauseQweightQgain),Qcost
oQStep3
ThreeQdrugQcombination
Q



Metformin
Q



PlusQ2QotherQdrugsQfromQstepQ2
Q



oQDecidedbasedonadrugandpatientspecificconsiderations
oQStep4
IfQ3QdrugQcombinationQthatQincludesQbasalQinsulinQfailsQafterQ3-6Qmonths,Qmore
Q



complexQinsulinQregimen
UsuallyQinQcombinationQwithQoneQorQmoreQnon-insulinQmedications
Q




WhenQaQpatientQisQonQinsulinQtherapyQwhatQareQtheQbloodQglucoseQgoalsQbeforeQmeals?QAtQbedtime?Q-
QcorrectQanswer-Beforemeals—70-130

,oQBedtime—100-140


WhatQisQtheQA1CQgoal?QWhenQisQgoalQbelowQ7QnotQappropriate?Q-QcorrectQanswer-
7%orQbelowQoQThoseQwithQsevereQhypoglycemiaQrisk,QlimitedQlifeQexpectancyQ,advancedQmicrovascularQo
r
macrovascularQcomplications—notQbelowQ7


WhatQareQtheQshortQactingQinsulins?QIntermediate?QLongQacting?Q-QcorrectQanswer-
Shortduration:Rapidacting
InsulinQlisproQ[Humalog]
Q



InsulinQaspartQ[NovoLog]
Q



InsulinQglulisineQ[Apidra]QoQShortduration:Sloweracting
Q



RegularQinsulinQ[HumulinQR,QNovolinQR]QoQIntermediateduration
Q



NeutralQprotamineQHagedornQ(NPH)Qinsulin
Q



InsulinQdetemirQ[Levemir]QoQLongduration
Q



InsulinQglargine
Q




WhenQareQshortQdurationQinsulinsQused?Q-QcorrectQanswer-
AdministeredQinQassociationQwithQmealsQtoQcontrolQtheQpost-
prandialQriseQinQbloodQglucoseQbetweenQmealsQandQatQnight


WhenQareQintermediateQinsulinsQneeded?Q-QcorrectQanswer-AdministerQ2-
3QtimesQdailyQtoQprovideQglycemicQcontrolQbetweenQmealsQandQduringQthe
night


HowQlongQisQdurationQofQglargine?QLevemir?QDegludec?Q-QcorrectQanswer-Glargine—
upQtoQ24QhoursQoQLevemir
LowQdoseQ(0.2Qunits/kg)—12Qhours
Q



HighQdosesQ(0.4Qunits/kg)—20-24Qhours
Q



oQDegludec—upQtoQ42Qhours


WhatQareQroutesQofQadministration?QWhichQcanQbeQinhaled?Q-QcorrectQanswer-
SQQinjectionQIVQinfusion.QInhalation—Afrezza,QmealQtimeQinsulin

, TypicalQinsulinQdosingQforQtypeQ1?QTypeQ2?Q-QcorrectQanswer-
TotalQdosesQmayQrangeQfromQ0.1Qunit/kgQbodyQweightQtoQmoreQthanQ2.5Qunits/kgQType1
InitialQdosesQtypicallyQrangeQfromQ0.5-0.6Qunits/kgQperQdayQType2
Q



InitialQdosesQrangeQfromQ0.2-0.6Qunits/kgQperQday
Q



DosageQincreasedQorQdecreasedQaccordingQtoQcarbQintake,Qactivity
Q




WhatQareQtheQ3QdosingQschedules?Q-QcorrectQanswer-
oQTwiceQdailyQdosingQoQIntensiveQbasal/bolusQstrategyQoQContinuedQsubcutaneousQinsulin


HowQdoesQmetforminQwork?Q-QcorrectQanswer-
oQInhibitsQglucoseQproductionQinQtheQliveroQReducesQglucoseQabsorptionQinQtheQgutoQSensitizesQinsulinQre
ceptorsQinQtargetQtissuesQ(fatQandQskeletalQmuscle)QthusQincrease
glucoseQuptakeQandQresponseQtoQwhateverQinsulinQisQavailable


MetforminQWhatQareQsideQeffects?QBBQwarning?Q-QcorrectQanswer-oQGIQeffects—diarrhea
oQLacticQacidosis


HowQdoesQalcoholQeffect?Q-QcorrectQanswer-InhibitsQtheQbreakdownQofQlacticQacid


WhatQareQtheQtherapeuticQusesQotherQthanQDM?Q-QcorrectQanswer-oQGestationalQdiabetes
oQPCOS


SulfonylureasQ-QcorrectQanswer-oQFirstQgeneration
ChlorpropamideQ[Diabinese]
Q



TolazamideQ[Tolinase]
Q



TolbutamineQ[Orinase]
Q




oQSecondQGeneration:
GlyburideQ[Diabeta,QGlynase,QMicronase]QwithQmetforminQ[Glucovance]
Q



GlypizideQ(Glucotrol,QGlucotrolQXL);QwithQmetforminQ[metaglip])
Q

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller AcademicACHIEVER. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $10.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

56326 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$10.49
  • (0)
Add to cart
Added